Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS HoldingsJNDOF 88 Debt-to-Equity is 0.15 as of Feb. 2026, which is 63% below its 10-year median of 0.41. GuruFocus rates JNDOF with a GF Score™ of 88/100 and a GF Value™ of $40.14 (Fairly Valued). Among 705 Medical Devices & Instruments companies, JINS Holdings ranks better than 51.21% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for JINS Holdings's Debt-to-Equity or its related term are showing as below:
JNDOF'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.14 Med: 0.41 Max: 1.58
Current: 0.22
During the past 13 years, the highest Debt-to-Equity Ratio of JINS Holdings was 1.58. The lowest was 0.14. And the median was 0.41.
JNDOF's Debt-to-Equity is ranked better than 51.21% of 705
companies
in the Medical Devices & Instruments industry
Industry Median: 0.23
vs JNDOF: 0.22
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
JINS Holdings Debt-to-Equity Related Terms
JINS Holdings Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for JINS Holdings's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JNDOF vs ISRG, BDX, MDLN: Debt-to-Equity Comparison
For the Medical Instruments & Supplies subindustry, JINS Holdings's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings Debt-to-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where JINS Holdings's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JINS Holdings (JNDOF) has a Debt-to-Equity of 0.15 as of Feb. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on JINS Holdings and its competitors. This is 63% below median its historical median of 0.41. Over the past decade, JINS Holdings' Debt-to-Equity has ranged from 0.14 to 1.58. According to the industry distribution chart, JINS Holdings ranks #344 out of 705 companies in the Medical Devices & Instruments industry, placing it in the top 48.8%.
Is JINS Holdings' Debt-to-Equity too high?
JINS Holdings' current Debt-to-Equity of 0.15 is 63% below median its 10-year median of 0.41. Over the past 10 years, this metric has ranged from a low of 0.14 to a high of 1.58. The Medical Devices & Instruments industry median Debt-to-Equity is 0.23. JINS Holdings' value of 0.15 is 34.8% below this industry median. Based on the distribution chart, JINS Holdings ranks #344 out of 705 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, JINS Holdings has a GF Score™ of 88/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' Debt-to-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #344 out of 705 companies for Debt-to-Equity. This puts JINS Holdings in the upper half of its industry. The industry median Debt-to-Equity is 0.23. JINS Holdings' value of 0.15 is 34.8% below this benchmark. Historically, JINS Holdings' own Debt-to-Equity has ranged from 0.14 to 1.58 over the past decade. While the company's 10-year median is 0.41 vs. the industry median of 0.23, JINS Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Medical Devices & Instruments company?
The median Debt-to-Equity among Medical Devices & Instruments companies is 0.23, based on 705 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current Debt-to-Equity of 0.15 is 34.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median Debt-to-Equity is 0.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current Debt-to-Equity is 0.15, which is 63% below median its own 10-year median of 0.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
Based on GuruFocus' analysis, JINS Holdings (JNDOF) is currently considered Fairly Valued. The stock's GF Value™ is $40.14, compared to a current price of $38.43 — trading 4.3% below its estimated fair value. The current Debt-to-Equity is 0.15, which is 63% below median its 10-year median of 0.41 and 34.8% below the Medical Devices & Instruments industry median of 0.23. JINS Holdings' overall GF Score™ is 88/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For JINS Holdings (JNDOF), the current Debt-to-Equity is 0.15 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (JNDOF) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of $38.43 is trading 4.3% below its estimated GF Value™ of $40.14.
GuruFocus considers JINS Holdings to be Fairly Valued.
Key valuation signals for JNDOF:
Debt-to-Equity: 0.15 (63% below median its 10-year median of 0.41)
GF Value™: $40.14 vs. price of $38.43 (4.3% below fair value)
Industry Position: 34.8% below the Medical Devices & Instruments median (#344 of 705)
No single metric tells the full story. See the JNDOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
88GF Score
Get the complete analysis for JNDOF
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JNDOF has been successfully added to your 
